Dramatic improvement of psoriatic erythroderma after acute hepatitis: Analysis of cytokine synthesis capability in peripheral blood T cells

British Journal of Dermatology

Volumn 155, Issue 2, 2006, Pages 455-459

  Kano, Y ^a   Teraki, Y ^a   Shiohara, T ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cd8+ T cells; Etretinate; Hepatitis C virus; Interferon ; Psoriasis

Indexed keywords

BETAMETHASONE VALERATE; COLECALCIFEROL; CORTICOSTEROID; ETRETINATE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4;

ADULT; ARTICLE; BLOOD; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; CYTOMEGALOVIRUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPHY; EPSTEIN BARR VIRUS; ERYTHRODERMA; EVALUATION; HEPATITIS C; HUMAN; IMMUNOASSAY; LABORATORY TEST; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ACUTE DISEASE; CYTOKINES; DERMATITIS, EXFOLIATIVE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SKIN; T-LYMPHOCYTE SUBSETS;

EID: 33745908627     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07270.x     Document Type: Article

References (19)

1. Prinz JC. Which T cells cause psoriasis? Clin Exp Dermatol 1999; 24:291-5.
2. Uyemura K, Yamamura M, Fiverson DF et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993; 101:701-5.
3. Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102:145-9.
4. Szabo SK, Hammerberg C, Yoshida Y et al. Identification and quantitation of interferon-γ producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. J Invest Dermatol 1998; 111:1072-8.
5. Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999; 155:145-58.
6. Austin LM, Ozawa M, Kikuchi T et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999; 113:752-9.
7. Teraki Y, Hotta T, Shiohara T. Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis. Br J Dermatol 2000; 143:373-8.
8. Picker LJ, Treer JR, Ferguson-Darnell B et al. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 1993; 150:1122-36.
9. Kano Y, Chiba M, Yagita A, Shiohara T. Complete resolution of psoriasis vulgaris after excision of thyroid cancer. Int J Dermatol 1997; 37:280-2.
10. Kanamori H, Tanaka M, Kawaguchi H et al. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia; case report and review of the literature. Am J Hematol 2002; 71:41-4.
11. Toichi E, Tachibana T, Furukawa F. Rapid improvement of psoriasis vulgaris during drug-induced agranulocytosis. J Am Acad Dermatol 2000; 43:391-5.
12. Piskin G, Tursen U, Sylva-Steenland RM et al. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-γ inducers IL-12, IL-18 and IL-23. Exp Dermatol 2004; 13:764-72.
13. Piskin G, Tursen U, Bos JD, Teunissen MB. IL-4 expression by neutrophils in psoriasis lesional skin upon high-dose UVB exposure. Dermatology 2003; 207:51-3.
14. Ghoreschi K, Mrowietz U, Rocken M. A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses. J Mol Med 2003; 81:471-80.
15. Hashizume H, Takigawa M. Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Derm Venereol (Stockh) 2005; 85:47-50.
16. Murata H, Shimizu Y, Okada K et al. Detection and analysis of intracytoplasmic cytokines in peripheral blood mononuclear cells in patients with drug-induced liver injury. J Hepatol 2003; 38:573-82.
17. Wedemeyer H, He XS, Nascimbeni M et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002; 169:3447-58.
18. Harries MJ, Chalmers RJ, Griffiths CE. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Br J Dermatol 2005; 153:549-51.
19. Litjens NH, Nibbering PH, Barrois AJ et al. Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with down-regulation of type 1 cytokines. Br J Dermatol 2003; 148:444-51.